Kimberly-Clark CEO Mike Hsu told CNBC's Jim Cramer that his company's acquisition of Tylenol maker Kenvue will create value for shareholders, even as the pain reliever is scrutinized by the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results